Abstract
Chemo-refractory Hodgkin lymphoma (HL), especially after failure of high-dose therapy and autologous stem cell transplantation (ASCT), has a very poor......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
